Podcasts about cancer treatments

"Unlike our cancer indications where we use these medications often to activate the immune system to target cancerous cells, in noncancer indications, the goal is really to either suppress an overactive immune or inflammatory cells or modulate the immune system. Immune modulation by use of chemotherapy and immunotherapy can help reduce abnormal inflammation, decrease autoantibody production, and also can alter T-cell and B-cell activity," ONS member Kelsey Miller, MSN, RN, AGCNS-BC, OCN®, clinical nurse specialist in oncology and infusion therapy at Reading Hospital in West Reading, PA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about chemotherapy and immunotherapy for noncancer indications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by September 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of anticancer therapies for noncancer indications. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 152: Administer Rituximab Immunotherapy With Confidence ONS Voice articles: JAK1 Inhibitor Quickly Relieves ICI-Related Dermatitis Oncology Drug Reference Sheet: Cyclophosphamide Oncology Drug Reference Sheet: Methotrexate What Oncology Nurses Need to Know About Arboviral Disease in Patients Receiving B-Cell–Depleting or –Modulating Therapies ONS books: Access Device Guidelines: Recommendations for Nursing Practice and Education (fourth edition) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Clinical Journal of Oncology Nursing article: Early Recognition and Response of Chemotherapy-Induced Hypersensitivity Reactions: A Nursing Discussion ONS courses: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ Safe Handling Basics Vascular Access Devices ONS Huddle Cards: Anaphylaxis Monoclonal Antibodies ONS position statement: Education of the Nurse Who Administers and Cares for the Individual Receiving Antineoplastic Therapies American Academy of Neurology: Practice Guideline Recommendations: Disease-Modifying Therapies for Adults With Multiple Sclerosis American College of Rheumatology: Treatments National Multiple Sclerosis Society: Infused therapies Injectable therapies Medications Used Off-Label NCODA Patient Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The most common immunotherapy agent that's well known to both oncology and other autoimmune disorders is rituximab. And that is used for rheumatoid arthritis, granulomatous, and antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. And then it also has many off-label indications for other autoimmune disorders, such as lupus and multiple sclerosis. It's also used in immune thrombocytopenia and Sjogren's condition." TS 3:28 "Two common chemotherapy agents that come to mind that are used in lower doses for noncancer conditions are methotrexate, which helps modify the underlying disease process to reduce inflammation and preserve organ and joint function. And that's most commonly used rheumatology-wise first-line for rheumatoid arthritis and psoriatic arthritis. A second chemotherapy agent that's well known to oncology is cyclophosphamide, and that really serves as a powerful immunosuppressant for conditions such as ANCA-associated vasculitis and severe lupus nephritis." TS 3:57 "When talking about the monoclonal antibody frequency, it's often shorter in our oncology indications. We may see it weekly, every 21 days, every 28 days—compared to our autoimmune disorders that are months in between. This is really due to cancer cells continuously proliferating, so we need to stop the growth and not allow residual cancer cells to remain. And for the monoclonal antibodies, for example, rituximab again, it's depleting B cells that contribute to autoantibody production and inflammation. So targeting that after one to two infusions, the peripheral B cells are often depleted within days to weeks because of how well the drug works, how targeted it is. Those effects may persist for 6–12 months or even longer." TS 8:39 "Infection prevention education—it's so important to get to know the patient to individualize your teaching. For example, you need to know what matters most of the patients when they go home. Are they taking care of their grandchildren? Do they love to go outside and garden and do mulching? Are they cleaning up their chicken coop? So those kind of things, as a nurse, you can then help tailor your education so you can help prevent infection in these patients because I don't think just standard run-of-the-mill infection prevention teaching is as beneficial as when you can individualize it for that patient." TS 17:33 "If organizations are going to allow non-oncology nurses to administer, we just want to make sure that there is an established process or a protocol to administer rescue medications. That may include what you're already doing if you have a change in patient condition—calling for activating that emergency response system if you're in an inpatient setting. When we look at our ambulatory infusion centers that may have non-oncology nurses administering, you still have to have that training and competency verification and also emergency medical equipment readily available. That would include oxygen and your rescue medications. For the non-oncology nurse, some key points are to make sure that you check on your patient throughout these infusions and have that conversation up front to report any symptoms, both big and small." TS 23:06 "For safe handling, there are many misconceptions that it differs between cancer and non-cancer. When I first started at our organization, even some providers may minimize the risk for low-dose oral chemotherapy. However, it's still metabolized and excreted through our bodily fluids. And we know that traditional chemotherapy, like methotrexate and cyclophosphamide, is cytotoxic. So if a patient's prescribed them for noncancer indications, you still need to cover the basics, like shared bathrooms, what to do if there's contaminated linen, and also bring up the topic of contraception to ensure that our patients and their partners remain safe and do not get exposed." TS 27:13

Limiting the side effects of cancer treatments has been an animating force in the field of oncology for many years, and there's been progress to report on that front, but what if you could target cancer tumors without using radiation or chemotherapy and instead generate heat from inside the tumor to kill cells? That's the quest of our guest today, Dr. Hadiyah-Nicole Green, whose promising research using lasers and nanoparticles to eliminate tumors received Breakthrough Device Designation from the FDA earlier this year. “The laser beam that we're using is low power like a laser pointer, and without activation by the laser, the nanoparticles are harmless. Both are targeted just at the site of the tumor so because we don't use systemic delivery, we avoid all of the systemic side effects,” she explains.Dr. Green is also the founder and president of the Ora Lee Smith Cancer Research Foundation, named for an aunt who raised her and who died of cancer without pursuing curative treatment because of her fear of the side effects. Shortly after, her aunt's husband also died of cancer, opting for treatments that took a heavy toll on his body. “At 22 years old, I saw the horrors of cancer and the horrors of cancer treatment and just felt in my heart that there has to be something better than this,” she tells host Michael Carrese.On this fascinating episode of Raise the Line from Elsevier, we'll explore the science behind Dr. Green's approach, the challenges of raising the millions of dollars needed for human clinical trials, and rethinking the current funding landscape for cancer treatments.Mentioned in this episode:Ora Lee Smith Cancer Research Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

The key to personalizing Y90 may not just be treating the tumor, but understanding how much radiation a patient can tolerate, where to deliver it, and when to safely push the dose. In this episode of the BackTable Podcast, Drs. Tyler Sandow and Ryan Hickey join host Dr. Kavi Krishnasamy to explore strategies for using Y90 in hepatocellular carcinoma and liver metastases. They combine real-world data from a study of nearly 1,000 patients with insights into methodology and the many variables that influence these procedures. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Boston Scientific TheraSphere Y-90. --- Timestamps 00:00 - Introduction02:36 - Resection After Radioembolization06:07 - Personal Practices Between HCC and Liver Metases07:26 - Bridging Radiation Segmentectomy 11:22 - Understanding Portal Vein Tumor Thrombus14:21 - Preferences in Dosimetry Software17:57 - Liver Reserve Limits25:11 - Microsphere Activity and Density29:16 - Diving into PROACTIF33:32 - RCTs and Trial Challenges36:57 - Patient Diversity in PROACTIF41:42 - Extrahepatic Disease43:03 - Data Gaps and Takeaways45:32 - Defining Personalized Dosimetry and Bridging Software50:15 - Mixed Delivery Approaches and Dose Thresholds01:01:36 - Response and Local Control01:04:26 - Treating PVT Subgroups01:09:03 - Comparison Between Dosing and Survival01:15:03 - Differences in Patients Quality of Life After Transplantation01:26:34 - Wrap-Up and Credits --- More about this episode The discussion covers radiation segmentectomy and selective delivery, the nuances of portal vein tumor thrombus levels, and how multidisciplinary collaboration differs between resection and transplant. The doctors dive into the PROACTIF study, focusing on personalized dosimetry, dose escalation, trial challenges, tumor response, and survival outcomes across disease stages. Drs. Sandow and Hickey also explain the limits of Y90, such as lung shunts, liver reserve, and treated liver volume, and highlight how decision-making and tailored techniques are essential for improving outcomes in liver cancer care. --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Researchers at the University of Montana identified a unique mouse that may hold some clues for cancer research. This Andean mouse's high-elevation home is what attracted researchers.

In this fascinating episode of Bladder Cancer Matters, host Rick Bangs sits down with renowned bladder cancer expert Dr. Robert Svatek to discuss how the field has been transformed over the past 15 years—and where it's headed next. Dr. Svatek reflects on his journey from academic surgeon and researcher to Vice President of Clinical Development at CG Oncology, sharing behind-the-scenes insights into clinical trials, emerging immunotherapies and the collaborative effort required to bring promising new treatments from the laboratory to patients. Whether you're a patient, caregiver, advocate or healthcare professional, this conversation offers an inspiring look at the remarkable progress being made in bladder cancer research while acknowledging the challenges that remain. You'll also hear how patient participation in clinical trials is driving innovation and why experts are more optimistic than ever about the future of bladder cancer care.

On today's episode: Spiders that launch their prey into their web! Scientists are fighting cancer by making it cosplay as malaria. All that and more today on All Around Science...RESOURCESThis Newly Discovered Spider Builds a Unique Web That Catapults Ants Through the Air Phages could enable us to hijack vaccine immunity to kill cancer cells | New ScientistDiscovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors | NIHA Guide to Targeted Therapy Side Effects | Hirschfeld OncologyOrbital Data Centers: Spacecraft Constraints and Economic Viability | Cornell UniversityCREDITS:Writing - Bobby Frankenberger & Maura ArmstrongBooking - September McCrady THEME MUSIC by Andrew Allenhttps://twitter.com/KEYSwithSOULhttp://andrewallenmusic.com Hosted on Acast. See acast.com/privacy for more information.

"When you have benign conditions, we're actually treating 3 gray, so a significant difference [versus doses of 60 gray for brain cancer]. Typically, when you treat at a high dose, the goal is to destroy tissue, like cancer tissue or cancer cells. But when we give a low dose, the goal is actually to modulate inflammation. And what it does is it slows down those inflammatory cells or those cells that release the chemicals that cause pain and inflammation," Amanda Meyer, DNP, APRN, CNP, family nurse practitioner in the Department of Radiation Oncology at the Mayo Clinic in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation therapy for noncancer indications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 22, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of radiation to treat noncancerous conditions. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 365: Radiation-Associated Secondary Cancers Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices ONS Voice articles: Augmented Reality Simulations Reduce Patient Anxiety by Teaching Them About Radiation Therapy Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education Quick Quiz: Test Your Knowledge of Radiation Care Coordination ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS Radiation Oncology Conference Recordings Bundle™ ONS ROCN™ Certification Review™ Radiation Oncology 101: 2024 ONS Bridge™ Session ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Findings From the 2023 Radiation Oncology Nursing Role Delineation Study to Shape the Future of the Subspecialty The Role of Advanced Practice Providers in Radiation Oncology in 2025 ONS Huddle Cards: Radiation Radiobiology German Society for Radiation Oncology (DEGRO): Guidelines in Radiotherapy: Radiotherapy for Benign Diseases To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We always typically think of it as cancer treatment, but we can use radiation for noncancerous conditions, as well. And radiation was actually used for benign diseases right after the discovery of x-rays. By the 1920s it was used a lot for different types of musculoskeletal, dermatologic issues, and different types of inflammatory conditions. And over time, since the 1920s, we've actually really gotten a really good understanding of it." TS 1:37 "When we're looking at what are good candidate characteristics, we do typically like older patients, so patients over the age of 65. And the rationale behind that is we know that there is a potential for a secondary risk of a skin cancer about 20 to 30 years after getting low-dose radiation, like a basal cell or squamous cell skin cancer. The older the patient is, the less likely they are to have any adverse effects from that." TS 8:22 "When we do the low-dose radiation, they've tried other measures that haven't been successful. However, we don't want a patient who is so severe that they're ready for surgery, when they're bone on bone, because we know that radiation isn't as effective when they are that severe. So there's this sweet window where low-dose radiation works best in these patients." TS 9:39 "When we're treating with a little bit higher dose for like a Dupuytren's or a Ledderhose, because it's an anti-proliferative dose, those patients, they do get more skin redness, more dry skin. That's very temporary, and it resolves within a week or two after treatment. But really, we don't see any acute side effects. The long-term side effect of the radiation-induced malignancy, again, is a very low—0.05% according to some of the European guidelines." TS 12:34 "I really wish people appreciated how interdisciplinary this is. We need to get referrals from family medicine and from primary care and internal medicine and pain medicine physicians and inflammatory physicians and podiatry and pain specialists. And we really need to use this multidisciplinary approach to get earlier referrals for patients because there is this sweet window of time where low-dose radiation works the best." TS 18:40

This is not a medical episode — it's an episode born from care. When Sheila's daughter was diagnosed with Hodgkin's lymphoma, sewing became one of the ways she could offer comfort and dignity during treatment. In this episode, Sheila of SheilaLovesFabric on Instagram, talks about what she discovered: the garments that helped, the adjustments that mattered, the fabrics she used, and the things she would have loved to have known about earlier. Sheila's hope is that these insights will support others who are sewing for someone navigating cancer treatment, or that you might share this episode with someone who needs it. Cancer data in Australia, Overview of cancer in Australia, 2025 - Australian Institute of Health and Welfare Sewing suggestions to encourage gentle exercise include: Wide brim hats Oversize shirts A totebag A silk pillowcase A cape or poncho Wide brim hat or tubin Loose tank shirt Loose cardigan Sweatshirt in double gauze fabric Soft breathable natural fibres This episode of Sew Organised Style podcast for SewOver50 was both video and audio produced by Maria Theoharous in her sewing room. With permission of Sheila. Sound by Kaneef on Youtube Many thanks for the ongoing monthly support of the podcast's Patreon contributors. Their paid Patreon membership enables me to create these video and audio podcasts for free. You can subscribe to Sew Organised Style podcast, spelt with an s not a z, on all good podcast apps and on YouTube. And yes. If you live in Australia and decide to purchase your own Mimiquin, I'll be your body scanner for Mimiquins UK. Make sure you go back and listen to our free Sewover50 episodes on Sew Organised Style podcast. Tag your makes using @sharesewover50 to be able to find your makes in chronological order on Instagram I look forward to joining you in your sewing room next time. Stay safe everyone. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

- Overview of Common Eye & Vision Changes Related to Cancer Treatments - Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors - Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights - The Role of the Multidisciplinary Team - Tips to Manage Low Vision & How Eye Products Can Help You Manage Eye/Vision Changes - Clinical Trials: How Research Increases Your Treatment Options - Communicating with Your Health Care Team - Guidelines for Eye Examinations & Check-Ups - Quality-of-Life Concerns - Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of Open Notes - Questions for Our Panel of Experts

Send us Fan MailEvening Prayer (Cancer Treatments; New Cancer Diagnosis; Organ Failure; Balance Issues; Learning Put God First) #jesus #prayer #christianprayer #cancer #healing #organfailure #balance Thank you for listening, our heart's prayer is for you and I to walk daily with Jesus, our joy and peaceaimingforjesus.comYouTube Channel https://www.youtube.com/@aimingforjesus5346Instagram https://www.instagram.com/aiming_for_jesus/Threads https://www.threads.com/@aiming_for_jesusX https://x.com/AimingForJesusTik Tok https://www.tiktok.com/@aiming.for.jesus

The Health Minister has agreed to meet with a group of blood cancer specialists who wrote an open letter expressing their alarm at Kiwi patients dying unecessarily because Aotearoa is lagging behind with treatments. The dozens of doctors, nurses and clinician reseachers say New Zealand blood cancer patients are being deprived of modern, targetted, funded, go to treatments, that are available globally; including the myeloma drug, Daratumumab. Professor Judith Trotman is the Chair of the Australasian Leukaemia Lymphoma Research Group and an expat Kiwi-Australian haematolgist in Sydney she spoke to Lisa Owen.

In this episode of the Biohackingville podcast, host Rob Rene takes us on a journey to the TAM Center in Tijuana, joined by Dr. Luis Enrique Menes. They discuss the groundbreaking integrative cancer treatments offered at this newly rebranded facility. Dr. Mena explains the concept of translational medicine, the center's advanced laboratories, and the specifics of their cellular therapies. Rob shares his personal experience as a patient, highlighting the center's innovative dendritic cell therapy. The conversation also delves into the center's dedication to making advanced treatments more affordable and accessible. Tune in for an in-depth look at how TAM Center is transforming cancer care.

Dr. Patrick Soon-Shiong has been a pioneer, leading the way in cancer research. As the Founder,  Executive Chairman, Global Chief Medical & Technology Officer at ImmunityBio, Dr. Soon-Shiong is changing the paradigm in how to treat cancer. Our body needs a strong, healthy immune response to overcome cancer. Chemotherapy weakens the immune system significantly, essentially wiping out our body's best defense of cancer and tumors, the natural killer cell. The natural killer cells in our body destroy and kill cancer cells, without them, we are fighting a losing battle. Dr. Soon-Shiong's invention Anktiva, is a superagonist fusion complex that selectively activates Natural Killer (NK) cells and memory T cells enabling immune amplification rather than immune suppression. This treatment has shown long term success with over a million pages of data. This data is sitting in the hands of the FDA, but unfortunately our FDA has not reviewed it. Saudi Arabia on the other hand, has chosen longevity science and healthspan as a measure of GDP and has approved Anktiva for use in the country. This 30 minute outpatient procedure is now available in Saudi Arabia for patients dealing with cancer. Will the success of this treatment in Saudi Arabia convince the FDA to approve this treatment in America or will Americans be forced into medical tourism to treat cancer successfully and save lives? Featuring: Dr. Patrick Soon-Shiong Executive Chairman, Global Chief Medical & Technology Officer | ImmunityBio https://immunitybio.com/ My latest book Trump 2.0: The Revolution That Will Permanently Transform America is available for preorder, just click the link: https://a.co/d/67kKgje Today's show is sponsored by: Patriot Mobile Take a stand for faith, family, and freedom—switch to Patriot Mobile. Patriot Mobile provides PREMIUM service on all three major U.S. networks. Patriot Mobile is the same or even better coverage, backed by 100% U.S.-based customer support. Get unlimited data plans, mobile hotspots, international roaming, and more with Patriot Mobile. Take a stand as a PATRIOT by going to https://PatriotMobile.com/SPICER or call 972-PATRIOT for a FREE month! Joi + Blokes Are you dragging through your days with no energy, zero motivation and stubborn belly fat? That dad bod, brain fog, and lack of drive aren't character flaws—they're symptoms, usually tied to hormones. Joi + Blokes connects you with licensed clinicians that can tell you what's going on in your body and create a plan to fix it. TRT, peptide therapy, NAD+, enclomiphene—these are treatments that get to the root cause and help you feel stronger, sharper, and present. So, stop guessing and start getting answers. Head to http://joiandblokes.com/sean right now and use code sean for 50% OFF your labs and 20% OFF all supplements! ------------------------------------------------------------- 1️⃣ Subscribe and ring the bell for new videos: https://youtube.com/seanmspicer?sub_confirmation=1 2️⃣ Become a part of The Sean Spicer Show community: https://www.seanspicer.com/ 3️⃣ Listen to the full audio show on all platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast/the-sean-spicer-show/id1701280578 Spotify: https://open.spotify.com/show/32od2cKHBAjhMBd9XntcUd iHeart: https://www.iheart.com/podcast/269-the-sean-spicer-show-120471641/ 4️⃣ Stay in touch with Sean on social media: Facebook: https://facebook.com/seanmspicer Twitter: https://twitter.com/seanspicer Instagram: https://instagram.com/seanmspicer/ 5️⃣ Follow The Sean Spicer Show on social media: Facebook: https://facebook.com/seanspicershow Twitter: https://twitter.com/seanspicershow Instagram: https://instagram.com/seanspicershow Learn more about your ad choices. Visit megaphone.fm/adchoices

Getting a cancer diagnosis today can mean something very different than it meant a few decades ago.  Cancer is still deadly. But thanks to advances in detection and treatment, cancer for some people has turned into a manageable condition. A report from the American Cancer Society out this week shows that for the first time that the five-year survival rate for all cancers has reached 70 percent. Tumors are being found at earlier stages, when treatment can be more effective. Surgery and radiation have gotten more precise.  Researchers have refined their understanding of different types of cancers and developed new drugs that zero in on the unique biology of specific tumors.Maybe most importantly, researchers are figuring out how to use the body's own immune system to fight cancer in ways that doctors couldn't have imagined 20 years ago.  MPR News host Angela Davis talks with her guests about how cancer treatments are improving.Guests: Dr. Emil Lou is a medical oncologist and professor at the University of Minnesota Medical School who sees patients at M Health Fairview Masonic Cancer Clinic. He specializes in gastrointestinal cancers, such as colorectal and pancreas cancers, and is also involved in cancer research.  Dr. Rachel L McCaffrey is a breast surgical oncologist at Allina Health who specializes in treating breast cancer. 

In this talk, Rileen, a Senior Computational Biologist and Cancer Data Scientist, shares his professional journey from physics and computer science to cutting-edge cancer genomics and applied machine learning. From his early work in alternative splicing models to deep learning in medical imaging, Rileen explains how biology, data science, and AI intersect to transform cancer research.TIMECODES:00:00 Rileen's Career Journey and Education06:14 Understanding Alternative Splicing in Computational Biology10:56 Modeling Alternative Splicing with Machine Learning14:52 Model Error Analysis and Transition to Cancer Research18:37 What Is Cancer? Mutational Theory Explained21:45 Cancer Treatments and Causes24:57 Cancer Genomics and Tumor Models28:59 Comparing Cell Lines and Tumor Samples (Multi-omics Analysis)32:32 Machine Learning Applications in Cancer Research35:38 Deep Learning for Medical Imaging and Pathology39:17 Data Privacy and Applied ML Course Projects42:50 Learning Outcomes and Future Plans46:36 Industry Experience in Pharmaceutical Research50:14 Day in the Life of a Computational Biologist55:02 Advice for Current ML Students58:40 Project Management and Challenges in Genomics1:02:23 Public Data Sets and Cancer Research in GermanyConnect with Rileen:- Twitter - https://x.com/RileenSinha- Linkedin - https://www.linkedin.com/in/rileen-sinha-a644692/- Github - https://github.com/OptimistixConnect with DataTalks.Club:- Join the community - https://datatalks.club/slack.html- Subscribe to our Google calendar to have all our events in your calendar - https://calendar.google.com/calendar/r?cid=ZjhxaWRqbnEwamhzY3A4ODA5azFlZ2hzNjBAZ3JvdXAuY2FsZW5kYXIuZ29vZ2xlLmNvbQ- Check other upcoming events - https://lu.ma/dtc-events- GitHub: https://github.com/DataTalksClub- LinkedIn - https://www.linkedin.com/company/datatalks-club/ - Twitter - https://twitter.com/DataTalksClub - Website - https://datatalks.club/

In cancer research, the “seed and soil” hypothesis posits that the tumor is like a seed of misbehaving cells taking root in the body. Whether it grows—and where it grows—depends on the conditions, or soil. Since this hypothesis was proposed more than 100 years ago, most research and treatments have focused on the seed, or tumor. For nearly 50 years, Rakesh Jain has been studying the soil. But in a seed-focused field, his work was seen as wasteful and radical. Now, that very same research has led to seven FDA-approved treatments for diseases including lung and liver cancer, and earned him a National Medal of Science in 2016. Host Flora Lichtman talks with Jain about how his fringe idea led to lifesaving cancer treatments. Guest: Dr. Rakesh K. Jain studies the biology of tumors at Harvard Medical School and Massachusetts General Hospital as a professor of radiation oncology.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

With the right protocols (and the right team!), urology clinics can proactively manage the side effects of intravesical therapy. This in-studio episode from the 2025 NMIBC Creator Weekend™ series features unique perspectives from Vanderbilt nurse practitioner Meredith Donahue and surgical neuro-oncology nurse Brynn Moore, a surgical neuro-oncology nurse, both with focuses in urologic oncology. Hosted by Dr. Ruchika Talwar, we cover the practical and logistical considerations in intravesical therapy administration. --- This podcast is supported by: Ferring Pharmaceuticalshttps://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/ --- SYNPOSIS Donahue and Moore share their experiences with intravesical therapy, discussing practical issues such as patient management, scheduling, and handling side effects. They emphasize the importance of creating a supportive environment in clinics, proactive treatment plans, and ensuring effective communication among the multidisciplinary team. They also share resources and tips for nurses and nurse practitioners new to urologic oncology. --- TIMESTAMPS 00:00 - Introduction07:09 - Multidisciplinary Team Dynamics11:34 - Resources for Patients18:55 - Transvaginal Estrogen Cream26:56 - Optimizing Intravesical Therapy Clinics35:57 - The Importance of Multidisciplinary Collaboration36:27 - Conclusion

Interview with John Brognard, PhD

Interview with medical student Michael Sun

Board-certified urologist Dr. Jason B. Carter explains his role in the diagnosis of testicular cancer."It's important to understand that when you have a diagnosis like testicular cancer, to some degree, the urologist may be the quarterback in the beginning. With testicular cancer, the urologist is going to be the one you meet, get the initial procedures done, and do the post-op follow-up."I'm very fortunate to have an excellent radiation oncologist that I work with, and very fortunate to have a couple of very, very good medical oncologists that I work with."Definitely anytime you have any kind of cancer, including testicular cancer, it is always a team approach." He shares his insights on treating testicular patients at Unity Urology, his practice in East Tennessee. He has been providing quality urologic care since 2003 and opened Unity Urology in 2006 in Greenville, Tennessee. Other urologic conditions to know about: Dr. Carter talks about other urologic conditions such as low testosterone, other hormone therapies for men and women, infertility, incontinence, and erectile disfunction. He is a medical advisor for Aeroflow Urology.Dr. Carter's medical degree is from East Tennessee University. He completed a residency at the University Hospital and clinics in Columbia, Missouri. He is board-certified in urology by the American Board of Urology and a member of the American Urological Association and the Tennessee Medical Association. Send us a textSupport the showFind us on Twitter, Instagram, Facebook & Linkedin. If you can please support our nonprofit through Patreon.

Join the October Menopause Challenge: https://drgabriellelyon.com/forever-strong-menopause-challenge/Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comWhen you hear the word “radiation,” do you think of cancer, Chernobyl, or an airport scanner? In this powerful episode, Dr. Gabrielle Lyon sits down with Dr. Sanjay Mehta, a radiation oncologist, to completely redefine your understanding of radiation as a tool for medicine.Dr. Mehta reveals how modern technology has made radiation oncology incredibly precise, minimizing side effects for cancer patients. He also shares groundbreaking insights into the underutilized field of low-dose radiation therapy, a safe and effective treatment for common inflammatory conditions like arthritis, tendinitis, and plantar fasciitis. This conversation is a must-watch for anyone with chronic pain or a fear of radiation, offering a new path to health and healing.Chapter Markers0:00 - Intro0:42 - The biggest myths about radiation1:33 - Dr. Sanjay Mheta's introduction2:07 - Radiation as a treatment for prostate cancer3:41 - The side effects of surgery vs. radiation4:32 - The training of a radiation oncologist5:34 - Full-body scans and diagnosis7:48 - What is radiation?9:00 - The difference between medicine and poison10:50 - The electromagnetic spectrum12:21 - Ionizing vs. Non-ionizing radiation13:42 - How we are naturally exposed to radiation15:50 - The biggest myth about radiation18:50 - Hormesis and low-dose radiation21:10 - The evolution of radiation technology22:38 - Radiation in daily life (dentist X-rays)25:00 - Can all cancers be destroyed by radiation?26:43 - Why radiation doesn't always burn skin28:25 - How radiation treatment is planned32:27 - Side effects of prostate cancer surgery33:09 - Penile shortening and prostate surgery36:00 - The role of testosterone in prostate cancer38:37 - How radiation affects bodybuilders39:09 - Who is not a candidate for radiation?41:33 - Is radiation the standard of care for all cancers?42:32 - Debunking radiation fear (microwaves, etc.)44:38 - The airport scanner debate47:03 - Other sources of radiation exposure52:32 - Grounding and radiation54:40 - Low-dose radiation for musculoskeletal injuries55:50 - The history of low-dose radiation57:22 - The use of radiation in the 1800s59:42 - Cortisone vs. low-dose radiation for pain1:03:00 - Dr. Ma's personal story of treatment1:04:07 - The duration and protocol of low-dose radiation1:08:16 - Inflammation and low-dose radiation1:10:59 - The durability of radiation therapy1:12:00 - Reversal of disease1:17:22 - Radiation's effect on hip pain1:18:29 - Treating rheumatoid arthritis1:20:29 - Post-operative radiation1:22:11 - Low-dose radiation for Peyronie's disease1:24:42 - What's holding back adoption of this therapy in the US?1:26:45 - The future of low-dose radiation1:27:31 - How to book an appointment with Dr. Mehta1:28:09 - Closing RemarksWho is Dr. Sanjay Mehta? Dr. Sanjay Mehta has been treating cancer patients for over 25 years using state of the art radiation oncology technology. He is now successfully treating patients with arthritis, tendonitis, and plantar fasciitis with low dose radiation using proven European regimens. It is non invasive, painless, and covered by Medicare and most insurance plans.This episode is brought to you by:PaleoValley - Get 15% off automatically at

Aotearoa is at least a decade behind in blood cancer treatments, and that is driving highly trained doctors offshore, as well as patients according, a New Zealand haematologist working in Australia. It comes as blood cancer patients with Meyloma are forced to move to Australia to get drugs that cost hundreds of thousands of dollars here but are virtually free across the Tasman. New Zealand-trained haematologist Professor Judith Trotman works in Sydney and treats medical migrants from Aotearoa, she spoke to Lisa Owen.

The Cancer Therapies You're Not Being Told About This episode goes straight into the treatments that rarely make it past the walls of a conventional oncology clinic. I'm talking red light therapy, chlorine dioxide solution (CDS), and even urine therapy, modalities backed by real science, used around the world, and showing results in cancer recovery, thyroid health, autoimmune conditions, wound healing, autism, chronic fatigue, and more. I'm joined by Jonathan Otto, researcher, educator, and producer of groundbreaking health documentaries who pulls back the curtain on what's working for patients right now. He shares case studies you won't hear in a standard medical appointment, breaks down the research hiding in plain sight, and explains exactly how these approaches fit into real-world healing protocols. We're also taking on the myths, the misinformation, and the reasons therapies with Nobel Prize-level science behind them are still being ignored. This is a candid, fact-driven conversation designed to help you see your options clearly, so you can make informed decisions about your health without limits placed on you by outdated systems. If you've been told there's only one path forward, this episode will give you a much wider view. Connect with Jonathan Otto: Instagram: @jonno.otto

Human Papillomavirus (HPV) is a small DNA virus that infects skin and wet surfaces of the body. The virus is typically spread through vaginal, anal, or oral sex. There are over 100 different types of HPV. The most common types of HPV are found on the skin and appear as warts. It is one of the most common types of sexually transmitted infections worldwide. HPV is responsible for more than 90% of anal and cervical cancers. The high-risk types of HPV form in the back of the throat, also known as Oropharyngeal Cancer. Vivian F. Wu, MD, MPH, is a surgeon-scientist specializing in all cancers of the head and neck, including those of the tongue, throat, voice box, thyroid, skin, and salivary glands. She is the Director of the Head and Neck Cancer Center of Excellence at Saint John's Cancer Institute and Pacific Neuroscience Institute (PNI).

Dr. Jennifer Wargo is an Associate Professor in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center and a Stand Up To Cancer researcher. Jennifer is a physician scientist, and this means she splits her time between providing care to patients and doing research to find better ways of treating disease. Specifically, Jennifer performs surgeries and treats patients one day each week. She spends the rest of her week studying how to better treat patients with cancer and how cancer may ultimately be prevented. When she's not doing research or treating patients, Jennifer enjoys spending quality time with her family. Some of their favorite activities include going for walks, biking, hiking, and visiting the beach. Jennifer also likes to explore her creative side through art and photography, as well as to be active through running, biking, yoga, and surfing. She received her A.S. degree in nursing and B.S. degree in biology from Gwynedd-Mercy College. Afterwards, Jennifer attended the Medical College of Pennsylvania where she earned her M.D. Jennifer completed her Clinical Internship and Residency in General Surgery at Massachusetts General Hospital. Next, Jennifer was a Research Fellow in Surgical Oncology at the University of California, Los Angeles. She then accepted a Clinical Residency in General Surgery at Massachusetts General Hospital. From 2006-2008, Jennifer was a Clinical Fellow in Surgical Oncology at the National Cancer Institute of the National Institutes of Health. She then served on the faculty at Massachusetts General Hospital and Harvard University. In 2012, Jennifer received her MMSc. degree in Medical Science from Harvard University. Jennifer joined the faculty at The University of Texas MD Anderson Cancer Center in 2013. She is Board Certified by the American Board of Surgery, and she has received numerous awards and honors throughout her career. These have included the R. Lee Clark Prize and Best Boss Award from the MD Anderson Cancer Center, the Rising STARS and The Regents' Health Research Scholars Awards from the University of Texas System, the Outstanding Young Investigator and Outstanding Investigator Awards from the Society for Melanoma Research, as well as a Stand Up To Cancer Innovative Research Grant for her microbiome work. She has also received other awards for excellence in teaching, research, and patient care. In our interview, Jennifer shares more about her life and science.

- Health Freedom Movement and Nomination of Casey Means (0:00) - Hijacking of the Health Freedom Movement (2:29) - Trust in Government and Establishment Control (6:01) - Investigative Journalism and Epstein Files (6:40) - Delayed Promises and False Hope (11:43) - Introduction to Scott Gordon and Prompting AI Engines (17:24) - AI Reasoning and Natural Intelligence (21:21) - Practical Tips for Using AI Engines (47:36) - Ethical Considerations and Future Plans (1:13:12) - Enoch AI and Its Limitations (1:14:50) - Enoch AI's Capabilities and Future Improvements (1:28:28) - Introduction to "The Cancer Industry" Book (1:31:02) - Critique of Cancer Treatments and Industry Practices (1:37:45) - Mother's Day Special and Health Ranger Store Promotions (1:38:06) - Announcement of "Breaking the Chains" Docu Series (1:42:03) - Detailed Overview of "Breaking the Chains" Content (1:53:04) - Introduction to Unincorporated Nonprofit Associations (UNAs) (1:55:46) - Final Thoughts and Call to Action (2:03:18) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

PREVIEW: Colleague Gregory Copley speaks of the good news of King Charles' return to work after a rest for the cancer treatments. More later. 1817 CHARLES I.

Lisa Vanderpump announces major new moves in Las Vegas, is she one step closer to having a reality show there. Plus, who is the leak behind Kyle and Mauricio's divorce rumors, cheating rumors, and Morgan Wade hookup rumors? David Yontef from ‘Behind The Velvet Rope' podcast joins and dishes on Teddi Mellencamp and the latest news with her cancer battle. Plus, Paige and Craig update and can you believe that as we record this Karen Huger is in jail, WILDDDDD! Get Tickets To Our Virtual Live Podcast show May 1st at 7pm EDT. Here's the link for tickets: https://www.eventbrite.com/e/david-yontef-sarah-fraser-virtual-live-show-ask-us-anything-51-7pm-tickets-1276780297239?aff=erelexpmlt MY Go Big Podcasting Courses Are Here! Purchase Go Big Podcasting and learn to start, monetize, and grow your own podcast. USE CODE: Cyber10 for 10% OFF**SHOP my Amazon Marketplace - especially if you're looking to get geared-up to start your own Podcast!!!**https://www.amazon.com/shop/thesarahfrasershowShow is sponsored by:Amazfit.com/tsfs are the best, most affordable, and long-lasting performance watches! Use code TSFS for 10% OFFHometownHero.com for the BEST CBD and THC products that support Veterans, and use code TSFS to take 20% off your first purchaseHorizonfibroids.com get rid of those nasty fibroidsJunesJourney download the free game in the app store, find clues and solves mysteries with this fun game.LittleSaints.com use code TSFS for 20% off your first order, these are my FAV non-alcoholic cocktails, enjoy better sleep, less stress, and more!MeetFabric.com/TSFS join the thousands of parents who trust Fabric to help protect their family. Apply today in just minutesNutrafol.com use code TSFS for FREE shipping and $10 off your subscriptionProlonlife.com/tsfs 15% off sitewide plus a $40 bonus gift when you subscribe to their 5-Day Nutrition Program! ● Try their detox that has REAL FOOD and WORKS!Rula.com/tsfs to get started today. That's R-U-L-A dot com slash tsfs for convenient therapy that's covered by insurance.Quince.com/tsfs for FREE shipping on your order and 365 day returnsFollow me on Instagram/Tiktok: @thesarahfrasershow  ***Visit our Sub-Reddit: reddit.com/r/thesarahfrasershow for ALL things The Sarah Fraser Show!!!***Advertise on The Sarah Fraser Show: thesarahfrasershow@gmail.comGot a juicy gossip TIP from your favorite TLC or Bravo show? Email: thesarahfrasershow@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lisa Vanderpump announces major new moves in Las Vegas, is she one step closer to having a reality show there. Plus, who is the leak behind Kyle and Mauricio's divorce rumors, cheating rumors, and Morgan Wade hookup rumors? David Yontef from ‘Behind The Velvet Rope' podcast joins and dishes on Teddi Mellencamp and the latest news with her cancer battle. Plus, Paige and Craig update and can you believe that as we record this Karen Huger is in jail, WILDDDDD!  Get Tickets To Our Virtual Live Podcast show May 1st at 7pm EDT. Here's the link for tickets: https://www.eventbrite.com/e/david-yontef-sarah-fraser-virtual-live-show-ask-us-anything-51-7pm-tickets-1276780297239?aff=erelexpmlt  MY Go Big Podcasting Courses Are Here! Purchase Go Big Podcasting and learn to start, monetize, and grow your own podcast. USE CODE: Cyber10 for 10% OFF **SHOP my Amazon Marketplace - especially if you're looking to get geared-up to start your own Podcast!!!** https://www.amazon.com/shop/thesarahfrasershow Show is sponsored by: Amazfit.com/tsfs are the best, most affordable, and long-lasting performance watches! Use code TSFS for 10% OFF HometownHero.com for the BEST CBD and THC products that support Veterans, and use code TSFS to take 20% off your first purchase Horizonfibroids.com get rid of those nasty fibroids JunesJourney download the free game in the app store, find clues and solves mysteries with this fun game. LittleSaints.com use code TSFS for 20% off your first order, these are my FAV non-alcoholic cocktails, enjoy better sleep, less stress, and more! MeetFabric.com/TSFS join the thousands of parents who trust Fabric to help protect their family. Apply today in just minutes Nutrafol.com use code TSFS for FREE shipping and $10 off your subscription Prolonlife.com/tsfs 15% off sitewide plus a $40 bonus gift when you subscribe to their 5-Day Nutrition Program! ● Try their detox that has REAL FOOD and WORKS! Rula.com/tsfs to get started today. That's R-U-L-A dot com slash tsfs for convenient therapy that's covered by insurance. Quince.com/tsfs for FREE shipping on your order and 365 day returns Follow me on Instagram/Tiktok: @thesarahfrasershow   ***Visit our Sub-Reddit: reddit.com/r/thesarahfrasershow for ALL things The Sarah Fraser Show!!!*** Advertise on The Sarah Fraser Show: thesarahfrasershow@gmail.com Got a juicy gossip TIP from your favorite TLC or Bravo show? Email: thesarahfrasershow@gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices